August 17, 2017
1 min read
Save

MacuLogix board develops AMD consensus paper

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

MacuLogix has announced the launch of an optometric advisory board tasked with documenting the standard of care for treating age-related macular degeneration by developing a consensus paper.

The board is led by Greg Jackson, PhD, MacuLogix co-founder and chief technology officer. The group aims to publish the guidelines this fall, according to an announcement from the company.

The clinical advisors are:

Glenn S. Corbin, OD, of Wyomissing Optometric Center in Wyomissing, Pa.;

Steven G. Ferrucci, OD, FAAO, of Sepulveda VA Hospital in Sepulveda, Calif.;

Jeffry D. Gerson, OD, FAAO, of Grin Eye Care in Olathe, Kan.;

Paul M. Karpecki, OD, FAAO, of Kentucky Eye Institute in Lexington, Ky.;

Gary S. Kirman, OD, of Kirman Eye in Hummelstown, Pa.;

Pamela Lowe, OD, FAAO, of Professional Eye Care Center in Niles, Ill.; and

Laurie Sorrenson, OD, FAAO, of Lakeline Vision Source in Cedar Park, Texas.

“We are very excited to partner with these industry leaders and AdaptDx super-users to help us achieve our vision of eliminating blindness caused by age-related macular degeneration,” William McPhee, president and CEO of MacuLogix, said in the announcement. “Each advisor is an early adopter of technology and their collective experiences are helping us drive greater adoption of the AdaptDx.”

The clinical advisors will also serve as company ambassadors for MacuLogix.